BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6282748)

  • 1. Only the chemotactic subpopulation of human blood monocytes expresses receptors for the chemotactic peptide N-formylmethionyl-leucyl-phenylalanine.
    Falk W; Harvath L; Leonard EJ
    Infect Immun; 1982 May; 36(2):450-4. PubMed ID: 6282748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two neutrophil populations in human blood with different chemotactic activities: separation and chemoattractant binding.
    Harvath L; Leonard EJ
    Infect Immun; 1982 May; 36(2):443-9. PubMed ID: 7085067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity and reversibility of chemotactic deactivation of human monocytes.
    Falk W; Leonard EJ
    Infect Immun; 1981 May; 32(2):464-8. PubMed ID: 6265358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of specific receptors for N-formylated chemotactic peptides in a human monocyte cell line stimulated with lymphokines.
    Pike MC; Fischer DG; Koren HS; Snyderman R
    J Exp Med; 1980 Jul; 152(1):31-40. PubMed ID: 7400755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of a specific receptor for formyl-methionyl-leucyl-phenylalanine on th pulmonary alveolar macrophage and its relationship to chemotaxis and superoxide production.
    Spilberg I; Mehta J; Daughaday C; Simchowitz L
    J Lab Clin Med; 1981 May; 97(5):602-9. PubMed ID: 6260878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotactic receptor of cord blood granulocytes to the synthesized chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Nunoi H; Endo F; Chikazawa S; Namikawa T; Matsuda I
    Pediatr Res; 1983 Jan; 17(1):57-60. PubMed ID: 6300743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyl ester of N-formylmethionyl-leucyl-phenylalanine: chemotactic responses of human blood monocytes and inhibition of gold compounds.
    Ho PP; Young AL; Southard GL
    Arthritis Rheum; 1978; 21(1):133-6. PubMed ID: 414757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-formylmethionyl-leucyl-[3H]phenylalanine binding, superoxide release, and chemotactic responses of human blood monocytes that repopulate the circulation during leukapheresis.
    Alteri E; Leonard EJ
    Blood; 1983 Oct; 62(4):918-23. PubMed ID: 6309289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies.
    Jesaitis AJ; Naemura JR; Painter RG; Schmitt M; Sklar LA; Cochrane CG
    J Cell Biochem; 1982; 20(2):177-91. PubMed ID: 6302115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotaxis of purified human monocytes in vitro: lack of accessory cell requirement.
    Falk W; Leonard EJ
    Infect Immun; 1982 May; 36(2):591-7. PubMed ID: 7085073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of granulocyte response to the chemoattractant F-Met-Leu-Phe.
    Dahlgren C; Stendahl O
    Adv Exp Med Biol; 1982; 155():107-12. PubMed ID: 6297266
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotactic deactivation of human neutrophils: relationship to loss of cytotaxin receptor function and temporal nature of the phenomenon.
    Nelson RD; Fiegel VD; Herron MJ; Simmons RL
    J Reticuloendothel Soc; 1980 Sep; 28(3):285-94. PubMed ID: 7411541
    [No Abstract]   [Full Text] [Related]  

  • 14. Amphotericin B alters the affinity and functional activity of the oligopeptide chemotactic factor receptor on human polymorphonuclear leukocytes.
    Lohr KM; Snyderman R
    J Immunol; 1982 Oct; 129(4):1594-9. PubMed ID: 6286769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the rat neutrophil formyl peptide chemotaxis receptor.
    Marasco WA; Fantone JC; Freer RJ; Ward PA
    Am J Pathol; 1983 Jun; 111(3):273-81. PubMed ID: 6305198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A series of six ligands for the human formyl peptide receptor: tetrapeptides with high chemotactic potency and efficacy.
    Rot A; Henderson LE; Copeland TD; Leonard EJ
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):7967-71. PubMed ID: 2825171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of human monocyte chemoattractant binding by flow cytometry.
    Leonard EJ; Noer K; Skeel A
    J Leukoc Biol; 1985 Sep; 38(3):403-13. PubMed ID: 3861752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of indomethacin on the binding of the chemotactic peptide formyl-Met-Leu-Phe on human polymorphonuclear leukocytes.
    Cost H; Gespach C; Abita JP
    FEBS Lett; 1981 Sep; 132(1):85-8. PubMed ID: 6271584
    [No Abstract]   [Full Text] [Related]  

  • 19. Phagocytosis-induced modulation of human neutrophil chemotaxis receptors.
    Lane TA; Lamkin GC; Windle BE
    Blood; 1981 Aug; 58(2):228-36. PubMed ID: 6264995
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of in vitro preincubation of polymorphonuclear leukocytes on formylmethionyl-leucyl-phenylalanine-induced chemiluminescence.
    Dahlgren C; Stendahl O
    Infect Immun; 1982 Jul; 37(1):34-9. PubMed ID: 6286494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.